Ketamine Metabolite Plasma Levels as Potential Blood Markers of Ketamine Efficacy in Treatment Resistant Depression

被引：0
|
作者：
Spangemacher, M. [1 ,2 ]
Reinwald, J. [2 ,3 ]
Boettcher, M. [4 ]
Gilles, M. [2 ]
Walter, M. [5 ]
Sartorius, A. [2 ,3 ]
Gruender, G. [1 ]
机构：
[1] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Mol Neuroimaging, Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany
[3] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Translat Imaging, Mannheim, Germany
[4] MVZ Med Labs Dessau Kassel GmbH, Dessau, Germany
[5] Univ Tubingen, Med Fac Tuebingen, Dept Psychiat & Psychotherapy, Tubingen, Germany
来源：
PHARMACOPSYCHIATRY | 2022年 / 55卷 / 03期
关键词：
D O I：
10.1055/s-0042-1747662
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
20
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [41] Feasibility of continuation ketamine for treatment-resistant depression
    aan het Rot, Marije
    Mathew, Sanjay J.
    Collins, Katherine A.
    Perez, Andrew M.
    Murrough, James W.
    Reich, David L.
    Charney, Dennis S.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 220S - 220S
  • [42] Psychedelic approach to treatment resistant depression: ketamine way
    Santos, F.
    Ribeiro, P.
    Trigo, M.
    Oliveira, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S531 - S532
  • [43] Ketamine is effective in an animal model of treatment resistant depression
    Pereira, Vitor Silva
    Joca, Samia R. L.
    Wegener, Gregers
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 95 - 96
  • [44] Ketamine in Late Life Treatment-Resistant Depression
    Heard, Erika
    Sohail, Yousuf
    Nagar, Anusuiya
    Glass, Oliver M.
    Hermida, Adriana P.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (03): : S66 - S66
  • [45] Oral ketamine for the treatment of pain and treatment-resistant depression
    Schoevers, Robert A.
    Chaves, Tharcila V.
    Balukova, Sonya M.
    aan het Rot, Marije
    Kortekaas, Rudie
    BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (02) : 108 - 113
  • [46] Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
    Salloum, Naji C.
    Fava, Maurizio
    Freeman, Marlene P.
    Flynn, Martina
    Hoeppner, Bettina
    Hock, Rebecca S.
    Cusin, Cristina
    Iosifescu, Dan V.
    Trivedi, Madhukar H.
    Sanacora, Gerard
    Mathew, Sanjay J.
    Debattista, Charles
    Ionescu, Dawn F.
    Papakostas, George I.
    DEPRESSION AND ANXIETY, 2019, 36 (03) : 235 - 243
  • [47] Ketamine for the Treatment of Depression
    Howland, Robert H.
    JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2013, 51 (01) : 11 - 14
  • [48] Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review
    Ng, Jason
    Rosenblat, Joshua D.
    Lui, Leanna M. W.
    Teopiz, Kayla M.
    Lee, Yena
    Lipsitz, Orly
    Mansur, Rodrigo B.
    Rodrigues, Nelson B.
    Nasri, Flora
    Gill, Hartej
    Cha, Danielle S.
    Subramaniapillai, Mehala
    Ho, Roger C.
    Cao, Bing
    McIntyre, Roger S.
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 293 : 285 - 294
  • [49] Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
    aan het Rot, Marije
    Collins, Katherine A.
    Murrough, James W.
    Perez, Andrew M.
    Reich, David L.
    Charney, Dennis S.
    Mathew, Sanjay J.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (02) : 139 - 145
  • [50] Ketamine Anesthesia, Efficacy of Electroconvulsive Therapy, and Cognitive Functions in Treatment-Resistant Depression
    Rybakowski, Janusz K.
    Bodnar, Anna
    Krzywotulski, Milosz
    Chlopocka-Wozniak, Maria
    Michalak, Michal
    Rosada-Kurasinska, Jowita
    Bartkowska-Sniatkowska, Alicja
    JOURNAL OF ECT, 2016, 32 (03) : 164 - 168
12345